The Independent Voice of
European Private Equity

Advanced Search

Carlyle and Brighton Park back Indegene

Simon Thompson 3 February 2021

Lifesciences
  • Carlyle’s global network and deep pharmaceutical expertise, coupled with Brighton Park’s experience in the tech will accelerate Indegene's trajectory of growth. 

Related Articles

Naxicap Partners acquires majority stake in spare parts distributor ITAL Express

08/05/24

Patrimonium and Wille Finance invest in EM

08/05/24

Montagu-backed HTL Biotechnology carves out Modern Meadow biomedical division

08/05/24

Squire Patton Boggs hires leveraged finance partner

08/05/24

Livonia Partners invests in Baltic tech firm Telema

08/05/24

Archimed-backed Carso bolts on three firms, focuses on European expansion

07/05/24